Shares of Evolent Health (EVH) were up over 8% or to approximately $31 per share in late day trading on Thursday after announcing it has expanded its partnership with Humana (HUM) in a slides presentation prepared for the JP Morgan Healthcare conference.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EVH:
- Evolent Health price target raised to $51 from $44 at Piper Sandler
- Evolent Health management to meet with BTIG
- Evolent Health price target raised to $44 from $33 at Piper Sandler
- EVOLENT HEALTH ANNOUNCES ACQUISITION OF SPECIALTY ASSET NIA AND STRATEGIC PARTNERSHIP WITH CENTENE
- Evolent Health participates in a conference call with Truist